Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hantel

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Plos One|October 29, 2019
Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencingVidya Balagopal, Andrew Hantel, Sabah Kadri, et al.
Haematologica|August 10, 2023
Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemiaAndrew Hantel, Marlise R Luskin, Irum Khan, et al.
JAMA Network Open|September 11, 2024
Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null-Associated Neutrophil CountStephen P Hibbs, Laura Aiken, Kruti Vora, et al.
Cancer|November 25, 2020
Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatmentAndrew Hantel, Clark DuMontier, Oreofe O Odejide, et al.
Leukemia & Lymphoma|March 18, 2014
A new family with a germline ANKRD26 mutation and predisposition to myeloid malignanciesRafael Marquez, Andrew Hantel, Rachelle Lorenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2023
ASCO Ethical Guidance for the Practical Management of Oncology Drug ShortagesAndrew Hantel, Rebecca Spence, Polo Camacho, et al.
Leukemia & Lymphoma|March 11, 2017
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemiaNiloufer Khan, Andrew Hantel, Randall W Knoebel, et al.
The Lancet. Planetary Health|August 14, 2025
The ethics of climate change and health-care delivery: a national survey of US-based physiciansAndrew Hantel, Emily Senay, Fay J Hlubocky, et al.
British Journal of Haematology|November 17, 2011
Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcomeChadi Nabhan, Sonali M Smith, Irene Helenowski, et al.
Transfusion|July 12, 2021
Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromesGregory A Abel, Heidi D Klepin, Emily S Magnavita, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Plos One|October 29, 2019
Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencingVidya Balagopal, Andrew Hantel, Sabah Kadri, et al.
Haematologica|August 10, 2023
Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemiaAndrew Hantel, Marlise R Luskin, Irum Khan, et al.
JAMA Network Open|September 11, 2024
Cancer Trial Eligibility and Therapy Modifications for Individuals With Duffy Null-Associated Neutrophil CountStephen P Hibbs, Laura Aiken, Kruti Vora, et al.
Cancer|November 25, 2020
Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatmentAndrew Hantel, Clark DuMontier, Oreofe O Odejide, et al.
Leukemia & Lymphoma|March 18, 2014
A new family with a germline ANKRD26 mutation and predisposition to myeloid malignanciesRafael Marquez, Andrew Hantel, Rachelle Lorenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2023
ASCO Ethical Guidance for the Practical Management of Oncology Drug ShortagesAndrew Hantel, Rebecca Spence, Polo Camacho, et al.
Leukemia & Lymphoma|March 11, 2017
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemiaNiloufer Khan, Andrew Hantel, Randall W Knoebel, et al.
The Lancet. Planetary Health|August 14, 2025
The ethics of climate change and health-care delivery: a national survey of US-based physiciansAndrew Hantel, Emily Senay, Fay J Hlubocky, et al.
British Journal of Haematology|November 17, 2011
Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcomeChadi Nabhan, Sonali M Smith, Irene Helenowski, et al.
Transfusion|July 12, 2021
Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromesGregory A Abel, Heidi D Klepin, Emily S Magnavita, et al.
Pageof 7